Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Vaccine/Immunotherapy

Workplace availability, risk group and perceived barriers predictive of 2016â17 influenza vaccine uptake in the United States: A cross-sectional study

Vaccine | Sep 16, 2017 Vaccine/Immunotherapy

Immunologic response elicited in breast cancer patients receiving a NeuGcGM3-based vaccine as adjuvant therapy

Journal of Immunotherapy | Sep 15, 2017 Vaccine/Immunotherapy

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England

BMC Medicine | Sep 13, 2017 Vaccine/Immunotherapy

Impact of rotavirus vaccines in low and middle-income countries

Current Opinion in Infectious Diseases | Sep 13, 2017 Vaccine/Immunotherapy

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink

Vaccine | Sep 12, 2017 Vaccine/Immunotherapy

Improving hepatitis vaccination series completion in patients awaiting liver transplantation

The Journal for Nurse Practitioners | Sep 09, 2017 Vaccine/Immunotherapy

Declines in human papillomavirus (HPV)âassociated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008â2015

Clinical Infectious Diseases | Sep 08, 2017 Vaccine/Immunotherapy

A population-based assessment of the impact of 7- and 13-valent pneumococcal conjugate vaccines on macrolide-resistant invasive pneumococcal disease: Emergence and decline of streptococcus pneumoniae serotype 19a (cc320) with dual macrolide resistance mechanisms

Clinical Infectious Diseases | Sep 08, 2017 Vaccine/Immunotherapy

Generalisability of vaccine effectiveness estimates: An analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

BMJ Open | Sep 08, 2017 Vaccine/Immunotherapy

Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy

The Journal of Allergy and Clinical Immunology | Sep 07, 2017 Vaccine/Immunotherapy

« Prev 1 … 36 37 38 39 40 41 42 Next »

Workplace availability, risk group and perceived barriers predictive of 2016â17 influenza vaccine uptake in the United States: A cross-sectional study

Immunologic response elicited in breast cancer patients receiving a NeuGcGM3-based vaccine as adjuvant therapy

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England

Impact of rotavirus vaccines in low and middle-income countries

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink

Improving hepatitis vaccination series completion in patients awaiting liver transplantation

Declines in human papillomavirus (HPV)âassociated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008â2015

A population-based assessment of the impact of 7- and 13-valent pneumococcal conjugate vaccines on macrolide-resistant invasive pneumococcal disease: Emergence and decline of streptococcus pneumoniae serotype 19a (cc320) with dual macrolide resistance mechanisms

Generalisability of vaccine effectiveness estimates: An analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Workplace availability, risk group and perceived barriers predictive of 2016â17 influenza vaccine uptake in the United States: A cross-sectional study

Immunologic response elicited in breast cancer patients receiving a NeuGcGM3-based vaccine as adjuvant therapy

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England

Impact of rotavirus vaccines in low and middle-income countries

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink

Improving hepatitis vaccination series completion in patients awaiting liver transplantation

Declines in human papillomavirus (HPV)âassociated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008â2015

A population-based assessment of the impact of 7- and 13-valent pneumococcal conjugate vaccines on macrolide-resistant invasive pneumococcal disease: Emergence and decline of streptococcus pneumoniae serotype 19a (cc320) with dual macrolide resistance mechanisms

Generalisability of vaccine effectiveness estimates: An analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic

Workplace availability, risk group and perceived barriers predictive of 2016â17 influenza vaccine uptake in the United States: A cross-sectional study

Declines in human papillomavirus (HPV)âassociated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008â2015